Development of a Simple and Objective Prognostication Model for Patients with Advanced Solid Malignant Tumors Treated with Immune Checkpoint Inhibitors: A Pan-Cancer Analysis.
Asuka SanoYusuke InoueHirotoshi KikuchiKensuke FukuchiKazuhito FunaiAtsushi ImaiYuto MatsushitaKeita TamuraMasatoshi KitagawaHideaki MiyakePublished in: Targeted oncology (2022)
Although this is a simple and objective model, it may be used as a reliable tool to predict the outcomes of advanced cancer patients receiving ICIs across multiple tumor types.